NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/12/2018
Back to search
Official data from USPTO
PHARMADIVERSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMADIVERSION
ST13
US500000077673095Class
35
Filing
77673095
Registration
3676202
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/12/2018
Trademark type
Word
Nice classes
35
Filing date
02/18/2009
Registration date
09/01/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2018
Last transaction
09/12/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/13/2009
First use in commerce
01/13/2009
Drawing code
4
Owner type
16
Owner location
Boothwyn, PA
Examiner
GOODSAID, IRA
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PharmaDiversion, LLC
Representatives
PharmaDiversion, LLC
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consultation in the field of assisting organizations in managing controlled substances
Publications
History of USPTO decisions and trademark events.
24 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/12/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/12/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
09/01/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/01/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/01/2018
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/03/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/03/2015
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/24/2015
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
08/18/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/18/2015
ES8R
TEAS SECTION 8 RECEIVED
07/15/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2009
PUBO
PUBLISHED FOR OPPOSITION
06/16/2009
NPUB
NOTICE OF PUBLICATION
05/27/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/08/2009
ALIE
ASSIGNED TO LIE
05/08/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2009
DOCK
ASSIGNED TO EXAMINER
05/08/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
02/24/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/23/2009
NWAP
NEW APPLICATION ENTERED
02/21/2009
Continuous trademark protection
Get notified about every new filing that threatens PHARMADIVERSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.